TABLE 3.
Guyatt’s Responsiveness Statistics for Changes in Huntington Disease Health-Related Quality of Life
| Self-Reported Changes in Physical Health (From Anchor Items) |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline to 12 Months |
Baseline to 24 Months |
|||||||||||
| No Change in Health |
Declines in Health |
Improvement in Health |
No Change in Health |
Declines in Health |
Improvement in Health |
|||||||
| N | SRM | N | SRM | N | SRM | N | SRM | N | SRM | N | SRM | |
| Chorea CAT | 223 | 0.10 | 74 | 0.26 | 24 | −0.30 | 139 | 0.20 | 78 | 0.30 | 22 | 0.15 |
| Chorea SF | 220 | 0.06 | 73 | 0.20 | 24 | −0.19 | 137 | 0.21 | 77 | 0.44 | 22 | 0.27 |
| Speech Difficulties CAT | 225 | 0.05 | 76 | 0.21 | 21 | −0.24 | 142 | 0.14 | 83 | 0.28 | 18 | −0.02 |
| Speech Difficulties SF | 224 | 0.00 | 75 | 0.18 | 21 | −0.35 | 144 | 0.12 | 81 | 0.26 | 18 | −0.15 |
| Swallowing Difficulties CAT | 239 | 0.03 | 64 | 0.58 | 21 | −0.22 | 145 | 0.09 | 78 | 0.61 | 20 | 0.10 |
| Swallowing Difficulties SF | 241 | 0.08 | 61 | 0.64 | 21 | 0.01 | 145 | 0.19 | 76 | 0.71 | 20 | 0.40 |
| Upper Extremities CATa | 210 | −0.11 | 80 | −0.46 | 33 | 0.15 | 127 | −0.36 | 90 | −0.47 | 28 | −0.12 |
| Upper Extremities SFa | 211 | −0.12 | 80 | −0.44 | 33 | −0.02 | 128 | −0.17 | 90 | −0.43 | 28 | −0.06 |
| Lower Extremities CATa | 197 | −0.14 | 63 | −0.34 | 63 | 0.05 | 125 | −0.29 | 66 | −0.58 | 56 | −0.06 |
| Lower Extremities SFa | 197 | −0.13 | 63 | −0.40 | 63 | −0.06 | 125 | −0.26 | 66 | −0.46 | 56 | 0.08 |
| Clinician-Rated Changes in Function (From TFC) |
||||||||||||
| Baseline to 12 Months |
Baseline to 24 Months |
|||||||||||
| No Change in Health |
Declines in Health |
Improvement in Health |
No Change in Health |
Declines in Health |
Improvement in Health |
|||||||
| N | SRM | N | SRM | N | SRM | N | SRM | N | SRM | N | SRM | |
| Chorea CAT | 238 | 0.06 | 68 | 0.22 | 23 | 0.20 | 216 | 0.24 | 45 | 0.31 | 28 | −0.28 |
| Chorea SF | 234 | 0.04 | 68 | 0.10 | 23 | 0.07 | 214 | 0.30 | 44 | 0.46 | 27 | 0.00 |
| Speech Difficulties CAT | 236 | 0.01 | 68 | 0.17 | 23 | −0.06 | 216 | 0.16 | 44 | 0.32 | 28 | 0.01 |
| Speech Difficulties SF | 235 | −0.03 | 68 | 0.14 | 23 | −0.09 | 216 | 0.12 | 45 | 0.37 | 27 | −0.11 |
| Swallowing Difficulties CAT | 236 | 0.12 | 68 | 0.11 | 23 | −0.25 | 216 | 0.17 | 44 | 0.53 | 28 | 0.33 |
| Swallowing Difficulties SF | 236 | 0.15 | 69 | 0.30 | 22 | −0.15 | 215 | 0.33 | 45 | 0.54 | 26 | 0.42 |
| Upper Extremities CATa | 233 | −0.05 | 66 | −0.51 | 23 | −0.04 | 215 | −0.27 | 41 | −0.75 | 26 | −0.49 |
| Upper Extremities SFa | 235 | −0.15 | 66 | −0.41 | 23 | 0.24 | 217 | −0.25 | 42 | −0.42 | 26 | 0.11 |
| Lower Extremities CATa | 233 | −0.07 | 66 | −0.39 | 23 | 0.07 | 215 | −0.24 | 41 | −0.53 | 26 | −0.21 |
| Lower Extremities SFa | 234 | −0.10 | 66 | −0.44 | 23 | −0.01 | 217 | −0.28 | 42 | −0.48 | 26 | −0.07 |
Bold indicates effects size magnitudes that are consistent with the proposed hypotheses.
Higher scores indicate better Huntington Disease Health-Related Quality of Life.
SRM, standardized response mean; TFC, Unified Huntington Disease Rating Scale Total Functional Capacity; CAT, Computer Adaptive Test; SF, Short Form.